| ER stress signaling promotes the survival of cancer'persister cells' tolerant to EGFR tyrosine kinase inhibitors H Terai, S Kitajima, DS Potter, Y Matsui, LG Quiceno, T Chen, T Kim, ... Cancer research, canres. 1904.2017, 2017 | 94 | 2017 |
| To prime, or not to prime: that is the question DS Potter, A Letai Cold Spring Harbor symposia on quantitative biology, 030841, 2016 | 70 | 2016 |
| Inhibition of PI3K/BMX cell survival pathway sensitizes to BH3 mimetics in SCLC DS Potter, M Galvin, S Brown, A Lallo, CL Hodgkinson, F Blackhall, ... Molecular cancer therapeutics, molcanther. 0885.2015, 2016 | 38 | 2016 |
| BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737 DS Potter, P Kelly, O Denneny, V Juvin, LR Stephens, C Dive, CJ Morrow Neoplasia 16 (2), 147-157, 2014 | 32 | 2014 |
| Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active JS Garcia, HT Kim, HM Murdock, CS Cutler, J Brock, M Gooptu, VT Ho, ... Blood Advances, 2021 | 30 | 2021 |
| Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer DS Potter, R Du, P Bhola, R Bueno, A Letai Cell death & disease 12 (8), 1-12, 2021 | 21 | 2021 |
| Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics VW Daniels, JJ Zoeller, N van Gastel, KE McQueeney, S Parvin, DS Potter, ... Science Signaling 14 (686), 2021 | 16 | 2021 |
| Ex vivo culture of circulating tumour cell derived explants to facilitate rapid therapy testing in small cell lung cancer A Lallo, UW Berglund, K Frese, D Potter, T Helleday, C Dive European Journal of Cancer 61, S120, 2016 | 5 | 2016 |
| Dynamic BH3 profiling identifies active combinations with conventional chemotherapy in non-small cell lung cancer DS Potter, AG Letai Cancer Research 79 (13 Supplement), 2496-2496, 2019 | | 2019 |
